Creso Pharma Rides Cannabis Stock Momentum
–The below is a company-sponsored announcement–
Momentum for cannabis stocks continues to intensify, as international acceptance instils confidence in companies to develop and distribute legal products.
The confidence in the market was highlighted on Wednesday this week, when GW Pharmaceuticals Ltd. GWPH, announced it was being acquired by Jazz Pharmaceuticals PLC JAZZ in a $7 billion deal.
GW develops Epidiolex, a drug that won US Food and Drug Administration approval as a treatment for severe forms of childhood epilepsy in 2018, while JAZZ is a specialist in sleep medications.
“We don’t think this is the last deal we will see in the sector,” said Nawan Butt, portfolio manager of the Medical Cannabis and Wellness UCITS ETF UK:CBDX.
Creso Pharma Ltd secures four new purchase orders for its craft cannabis, including maiden order from Canadian Province of New Brunswick
proactiveinvestors.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com.au Daily Mail and Mail on Sunday newspapers.
S&P/ASX 200 rises for a third day after RBA leaves cash rate unchanged
proactiveinvestors.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com.au Daily Mail and Mail on Sunday newspapers.